{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T15:42:07Z","timestamp":1760715727232,"version":"build-2065373602"},"reference-count":33,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Suining Health Science and Technology Program","award":["24CJDFB30"],"award-info":[{"award-number":["24CJDFB30"]}]},{"name":"Suining Health Science and Technology Program","award":["SN2023B09"],"award-info":[{"award-number":["SN2023B09"]}]},{"name":"Suining City Chinese Medicine Research Special Project","award":["24CJDFB30"],"award-info":[{"award-number":["24CJDFB30"]}]},{"name":"Suining City Chinese Medicine Research Special Project","award":["SN2023B09"],"award-info":[{"award-number":["SN2023B09"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Cir. Bras."],"abstract":"<jats:p>ABSTRACT  Purpose: To investigate the optimal therapeutic sequence of rhGM-CSF combined with hypofractionated radiotherapy (HFRT) in treating mouse pancreatic cancer (PC) and explore the mechanisms.  Methods: A PC-bearing model was established. The antitumor effects were observed under rhGM-CSF, HFRT, rhGM-CSF + HFRT, rhGM-CSF&amp;HFRT, and HFRT + rhGM-CSF treatments. Tumor histopathological changes were examined using hematoxylin and eosin (H&amp;E) staining. FCM was employed to detect calreticulin (CRT), mDCs, CD4+, and CD8+ T cells. Enzyme-linked immunosorbent assay (ELISA) was used to measure HMGB1, adenosine triphosphate (ATP), interleukin- (IL)-2, IL-4, IL-8, IL-10, IL-12, IFN-\u03b3, tumor necrosis factor (TNF)-\u03b1, and iNOS levels. IF staining was performed to detect CD31 and \u03b1-smooth muscle actin, and immunohistochemistry was used to detect vascular endothelial growth factor (VEGF), soluble VEGF receptor-1 (sVEGFR-1), hypoxia-inducible factor- (HIF)-1\u03b1, and HIF-2\u03b1 expression.  Results: HFRT + rhGM-CSF inhibited tumor growth, promoted tumor necrosis, and increased inflammatory cell infiltration. This regimen also significantly enhanced immunogenic cell death by inducing CRT exposure and the release of HMGB1 and ATP. Furthermore, HFRT + rhGM-CSF markedly increased proportions of mDCs, CD4+ T cells, and CD8+ T cells, and upregulated expressions of IL-2, IL-8, IL-12, IFN-\u03b3, TNF-\u03b1, and iNOS, but not IL-4 and IL-10. Additionally, rhGM-CSF synergized with HFRT to promote the normalization of blood vessels in the PC.  Conclusion: HFRT followed by rhGM-CSF had the best efficacy in PC, and the molecular mechanism may be related to immunogenic cell death.<\/jats:p>","DOI":"10.1590\/acb407625","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T15:02:02Z","timestamp":1760713322000},"source":"Crossref","is-referenced-by-count":0,"title":["Hypofractionated radiotherapy followed by rhGM-CSF enhances immunogenic cell death in a murine model of pancreatic cancer"],"prefix":"10.1590","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0040-1617","authenticated-orcid":false,"given":"Junli","family":"Tang","sequence":"first","affiliation":[{"name":"Suining First People\u2019s Hospital,  China; Southwest Medical University,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9763-5485","authenticated-orcid":false,"given":"Fei","family":"Chen","sequence":"additional","affiliation":[{"name":"Suining First People\u2019s Hospital,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5835-3832","authenticated-orcid":false,"given":"Hui","family":"Xia","sequence":"additional","affiliation":[{"name":"Suining First People\u2019s Hospital,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6203-2755","authenticated-orcid":false,"given":"Chao","family":"Wang","sequence":"additional","affiliation":[{"name":"Suining First People\u2019s Hospital,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7855-357X","authenticated-orcid":false,"given":"Rui","family":"Tang","sequence":"additional","affiliation":[{"name":"Suining First People\u2019s Hospital,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3609-5747","authenticated-orcid":false,"given":"Shu","family":"Luo","sequence":"additional","affiliation":[{"name":"Suining First People\u2019s Hospital,  China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2025]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"885","DOI":"10.18632\/aging.101785","article-title":"Three hypomethylated genes were associated with poor overall survival in pancreatic cancer patients","volume":"11","author":"Chen H","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.3390\/jcm9113720","article-title":"Risk of developing pancreatic cancer in patients with chronic pancreatitis","volume":"9","author":"Vujasinovic M","year":"2020","journal-title":"J Clin Med"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pan.2014.10.001","article-title":"Addressing the challenges of pancreatic cancer: future directions for improving outcomes","volume":"15","author":"Hidalgo M","year":"2015","journal-title":"Pancreatology"},{"key":"ref4","first-page":"21","article-title":"Comparison of the dose escalation potential for two hypofractionated radiotherapy regimens for locally advanced pancreatic cancer","volume":"16","author":"Bertholet J","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"496","DOI":"10.21037\/jgo-21-160","article-title":"Dosimetric feasibility on hypofractionated intensity-modulated radiotherapy and simultaneous integrated boost for locally advanced unresectable pancreatic cancer with helical tomotherapy","volume":"12","author":"Teng F","year":"2021","journal-title":"J Gastrointest Oncol"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3390\/cells11060935","article-title":"GM-CSF protects macrophages from DNA damage by inducing differentiation","volume":"11","author":"Vico T","year":"2022","journal-title":"Cells"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/15384047.2016.1276133","article-title":"Abscopal effect of metastatic pancreatic cancer after local radiotherapy and granulocyte-macrophage colony-stimulating factor therapy","volume":"18","author":"Shi F","year":"2017","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1189\/jlb.0311171","article-title":"Natural killer cell-mediated response to human cytomegalovirus-infected macrophages is modulated by their functional polarization","volume":"90","author":"Romo N","year":"2011","journal-title":"J Leukoc Biol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3389\/fimmu.2017.00625","article-title":"Phase II study of adjuvant immunotherapy with the CSF-470 vaccine plus bacillus calmette-guerin plus recombinant human granulocyte macrophage-colony stimulating factor vs medium-dose interferon alpha 2B in stages IIB, IIC, and III cutaneous melanoma patients: A single institution, randomized study","volume":"8","author":"Mordoh J","year":"2017","journal-title":"Front Immunol"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1038\/s41598-017-04978-x","article-title":"Hypofractionated stereotactic radiation therapy activates the peripheral immune response in operable stage I non-small-cell lung cancer","volume":"7","author":"Zhang T","year":"2017","journal-title":"Sci Rep"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1470-2045(15)00054-6","article-title":"Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial","volume":"16","author":"Golden EB","year":"2015","journal-title":"Lancet Oncol"},{"issue":"10","key":"ref12","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.4049\/jimmunol.2300326","article-title":"Dose-specific intratumoral GM-CSF modulates breast tumor oxygenation and antitumor immunity","volume":"211","author":"Mihalik NE","year":"2023","journal-title":"J Immunol"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijrobp.2020.05.002","article-title":"Effect of low-dose radiation therapy on abscopal responses to hypofractionated radiation therapy and anti-PD1 in mice and patients with non-small cell lung cancer","volume":"108","author":"Yin L","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6801","key":"ref14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet P","year":"2000","journal-title":"Nature"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrc1934","article-title":"Hepatocellular carcinoma pathogenesis: from genes to environment","volume":"6","author":"Farazi PA","year":"2006","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/14728222.2017.1282465","article-title":"Vessel pruning or healing: endothelial metabolism as a novel target?","volume":"21","author":"Cantelmo AR","year":"2017","journal-title":"Expert Opin Ther Targets"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201745054","article-title":"EphrinB2\/EphB4 signaling regulates non-sprouting angiogenesis by VEGF","volume":"19","author":"Groppa E","year":"2018","journal-title":"EMBO Rep"},{"issue":"19","key":"ref18","first-page":"4082","article-title":"Roles of PECAM-1 in cell function and disease progression","volume":"20","author":"Feng YM","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref19","article-title":"CD31 promotes diffuse large B-cell lymphoma metastasis by upregulating OPN through the AKT pathway and inhibiting CD8+ T cells through the mTOR pathway","author":"He Z","year":"2023","journal-title":"Am J Transl Res"},{"issue":"7 Suppl.","key":"ref20","doi-asserted-by":"crossref","first-page":"12S","DOI":"10.1097\/01.prs.0000225430.42531.c2","article-title":"The basic science of wound healing","volume":"117","author":"Broughton 2nd G","year":"2006","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"ref21","first-page":"372","article-title":"Induction of alpha-smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-beta 1","volume":"144","author":"Verbeek MM","year":"1994","journal-title":"Am J Pathol"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3109\/10715762.2012.669041","article-title":"Role of reactive oxygen species in the regulation of HIF-1 by prolyl hydroxylase 2 under mild hypoxia","volume":"46","author":"Niecknig H","year":"2012","journal-title":"Free Radic Res"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.21037\/jgo-23-844","article-title":"Activation of RhoA\/ROCK2 signaling by hypoxia-inducible factor 1alpha in promoting tumor growth and metastasis in human colon cancer","volume":"15","author":"Du K","year":"2024","journal-title":"J Gastrointest Oncol"},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/cac2.12034","article-title":"Ovarian cancer-excreted exosomal miR-199a-5p suppresses tumor metastasis by targeting hypoxia-inducible factor-2alpha in hypoxia microenvironment","volume":"40","author":"Lian XY","year":"2020","journal-title":"Cancer Commun (Lond)"},{"issue":"22","key":"ref25","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.153242","article-title":"Targeting TNF-alpha-producing macrophages activates antitumor immunity in pancreatic cancer via IL-33 signaling","volume":"7","author":"Dixit A","year":"2022","journal-title":"JCI Insight"},{"issue":"12","key":"ref26","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko DV","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1038226","DOI":"10.3389\/fimmu.2022.1038226","article-title":"Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy","volume":"13","author":"Palanivelu L","year":"2022","journal-title":"Front Immunol"},{"issue":"10","key":"ref28","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1084\/jem.20101159","article-title":"Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8alpha+ dendritic cells","volume":"208","author":"Fuertes MB","year":"2011","journal-title":"J Exp Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and cancer","volume":"37","author":"McLane LM","year":"2019","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1182\/blood-2008-12-195792","article-title":"Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired","volume":"114","author":"Ahmadzadeh M","year":"2009","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1228532","DOI":"10.3389\/fimmu.2023.1228532","article-title":"Intracellular Salmonella delivery of an exogenous immunization antigen refocuses CD8 T cells against cancer cells, eliminates pancreatic tumors and forms antitumor immunity","volume":"14","author":"Raman V","year":"2023","journal-title":"Front Immunol"},{"issue":"7780","key":"ref32","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41586-019-1671-8","article-title":"MHC-II neoantigens shape tumour immunity and response to immunotherapy","volume":"574","author":"Alspach E","year":"2019","journal-title":"Nature"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ccell.2018.05.004","article-title":"Th9 cells represent a unique subset of CD4(+) T cells endowed with the ability to eradicate advanced tumors","volume":"33","author":"Lu Y","year":"2018","journal-title":"Cancer Cell"}],"container-title":["Acta Cir\u00fargica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0102-86502025000100250&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T15:02:07Z","timestamp":1760713327000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0102-86502025000100250&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":33,"alternative-id":["S0102-86502025000100250"],"URL":"https:\/\/doi.org\/10.1590\/acb407625","relation":{},"ISSN":["1678-2674","0102-8650"],"issn-type":[{"value":"1678-2674","type":"electronic"},{"value":"0102-8650","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e407625"}}